Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.

Adeline A. Lau, Kim M. Hemsley, Adrian Meedeniya, Aaron J. Robinson, John J. Hopwood

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Lysosomal storage disorders are rare, inherited diseases caused by a deficiency of a specific, lysosomal enzyme. In the case of mucopolysaccharidosis type IIIA, a lack of active sulfamidase enzyme results in heparan sulfate accumulation, severe and progressive neurological deficits, and usually premature death. Embryonic stem cells can be genetically modified to overexpress lysosomal enzymes, providing a renewable reservoir of cells that can be readily expanded in culture. Screening clonal lines of embryonic stem cells for desirable properties such as high levels and maintenance of enzyme activity throughout terminal differentiation to neural phenotypes theoretically provides a reproducible population of cells that can be fully characterized in vitro before implantation within the central nervous system in animal models of lysosomal storage disorders.

LanguageEnglish
Pages471-484
Number of pages14
JournalMethods in molecular biology (Clifton, N.J.)
Volume329
Publication statusPublished - 2006
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Lau, Adeline A. ; Hemsley, Kim M. ; Meedeniya, Adrian ; Robinson, Aaron J. ; Hopwood, John J. / Directed differentiation and characterization of genetically modified embryonic stem cells for therapy. In: Methods in molecular biology (Clifton, N.J.). 2006 ; Vol. 329. pp. 471-484.
@article{f4b96d18c49249eeb4452051cedaa3c2,
title = "Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.",
abstract = "Lysosomal storage disorders are rare, inherited diseases caused by a deficiency of a specific, lysosomal enzyme. In the case of mucopolysaccharidosis type IIIA, a lack of active sulfamidase enzyme results in heparan sulfate accumulation, severe and progressive neurological deficits, and usually premature death. Embryonic stem cells can be genetically modified to overexpress lysosomal enzymes, providing a renewable reservoir of cells that can be readily expanded in culture. Screening clonal lines of embryonic stem cells for desirable properties such as high levels and maintenance of enzyme activity throughout terminal differentiation to neural phenotypes theoretically provides a reproducible population of cells that can be fully characterized in vitro before implantation within the central nervous system in animal models of lysosomal storage disorders.",
author = "Lau, {Adeline A.} and Hemsley, {Kim M.} and Adrian Meedeniya and Robinson, {Aaron J.} and Hopwood, {John J.}",
year = "2006",
language = "English",
volume = "329",
pages = "471--484",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

Directed differentiation and characterization of genetically modified embryonic stem cells for therapy. / Lau, Adeline A.; Hemsley, Kim M.; Meedeniya, Adrian; Robinson, Aaron J.; Hopwood, John J.

In: Methods in molecular biology (Clifton, N.J.), Vol. 329, 2006, p. 471-484.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.

AU - Lau, Adeline A.

AU - Hemsley, Kim M.

AU - Meedeniya, Adrian

AU - Robinson, Aaron J.

AU - Hopwood, John J.

PY - 2006

Y1 - 2006

N2 - Lysosomal storage disorders are rare, inherited diseases caused by a deficiency of a specific, lysosomal enzyme. In the case of mucopolysaccharidosis type IIIA, a lack of active sulfamidase enzyme results in heparan sulfate accumulation, severe and progressive neurological deficits, and usually premature death. Embryonic stem cells can be genetically modified to overexpress lysosomal enzymes, providing a renewable reservoir of cells that can be readily expanded in culture. Screening clonal lines of embryonic stem cells for desirable properties such as high levels and maintenance of enzyme activity throughout terminal differentiation to neural phenotypes theoretically provides a reproducible population of cells that can be fully characterized in vitro before implantation within the central nervous system in animal models of lysosomal storage disorders.

AB - Lysosomal storage disorders are rare, inherited diseases caused by a deficiency of a specific, lysosomal enzyme. In the case of mucopolysaccharidosis type IIIA, a lack of active sulfamidase enzyme results in heparan sulfate accumulation, severe and progressive neurological deficits, and usually premature death. Embryonic stem cells can be genetically modified to overexpress lysosomal enzymes, providing a renewable reservoir of cells that can be readily expanded in culture. Screening clonal lines of embryonic stem cells for desirable properties such as high levels and maintenance of enzyme activity throughout terminal differentiation to neural phenotypes theoretically provides a reproducible population of cells that can be fully characterized in vitro before implantation within the central nervous system in animal models of lysosomal storage disorders.

UR - http://www.scopus.com/inward/record.url?scp=33747626549&partnerID=8YFLogxK

M3 - Article

VL - 329

SP - 471

EP - 484

JO - Methods in molecular biology (Clifton, N.J.)

T2 - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -